Skip to main content
Browse Herbs Formula Lab Herbalism Programs Journal Career Paths Enroll Now

Herbal Monograph

Gravel root

Eutrochium purpureum (L.) E.E.Lamont

Asteraceae (Compositae)

Class 2d Diuretic Anti-inflammatory Antispasmodic

Traditional Eclectic urinary remedy for kidney stones and gravel — use with PA caution

Overview

Plant Description

Robust, herbaceous perennial, 0.9–2.1 m tall (occasionally to 3 m in rich, moist conditions). Stems erect, typically solid (not hollow), purplish or green with purple nodes and leaf junctions, usually unbranched below the inflorescence. Leaves whorled, typically in groups of 3–5 (most commonly 4), lanceolate to ovate-lanceolate, 8–30 cm long, 3–12 cm wide, serrate margins, glabrous above, finely pubescent below, with a distinctive vanilla-like fragrance when crushed — the species was reportedly named after a Native American healer called 'Joe Pye' who used it to treat typhoid fever. Inflorescence a large, terminal, dome-shaped or rounded corymb of numerous small, pinkish-purple to mauve flower heads; each head contains 5–7 tubular florets. Achenes 3–5 mm, 5-ribbed, with a whitish pappus for wind dispersal. Root system a dense, fibrous rootstock with a thick, woody rhizome; fresh root has a slightly bitter, aromatic odor.

Habitat

Moist to mesic woodland borders, thickets, meadows, and stream banks. Prefers partial shade to full sun in rich, calcareous or slightly alkaline soils. Commonly found along woodland edges, in moist bottomlands, and near streams and seeps. Tolerates a range of soil moisture but is most vigorous in consistently moist, well-drained loams.

Distribution

Native to eastern North America, ranging from southeastern Canada (Ontario, Quebec, New Brunswick) south through the eastern United States to Florida and west to the Great Plains (Minnesota, Iowa, Nebraska, Oklahoma, Texas). Most common in the Appalachian region and eastern deciduous forest zone. Not commercially cultivated on a large scale for medicinal use; primarily wild-harvested or garden-grown.

Parts Used

Root and rhizome (Eutrochii radix)

Preferred: Dried root decoction or tincture; standardized extracts with PA-free processing preferred

The root and rhizome are the primary medicinal parts used in the Eclectic and Western herbal traditions. The root contains the highest concentrations of bioactive flavonoids, euparin, and — critically — pyrrolizidine alkaloids. Traditional herbalists considered the fresh root more effective than dried, though most commercial preparations use dried root. Quality varies significantly by growing conditions, harvest timing, and processing. PA content should be assessed by reputable suppliers.

Aerial parts (flowering tops)

Preferred: Infusion of dried flowering tops

The flowering tops have been used less frequently but appear in some traditional formulations, particularly among Native American peoples. The leaves and flowers contain lower concentrations of the primary root constituents. Less commonly available commercially.

Key Constituents

Pyrrolizidine alkaloids (PAs)

Echinatine Variable; typically low but measurable in root
Echinatine N-oxide Variable

SAFETY CONCERN — NOT THERAPEUTIC. The pyrrolizidine alkaloids in gravel root are not considered therapeutically relevant; they are a toxicological liability. 1,2-unsaturated PAs such as echinatine are well-established hepatotoxins and potential genotoxic carcinogens. The European Medicines Agency (EMA), German BfR, and other regulatory bodies have established limits for PA intake (e.g., ≤0.35 µg/day for long-term exposure). The PA content of gravel root products is highly variable depending on plant part, chemotype, processing, and extraction method. Hot water extraction (decoction, infusion) may extract fewer PAs than hydroalcoholic tincture, but this is not guaranteed. Any internal use of gravel root requires awareness of PA risk and ideally PA-tested material.

Flavonoids and phenolic compounds

Euparin (6-acetyl-5-hydroxy-2-isopropenyl-7-methoxybenzofuran) Present in root and aerial parts
Eupatoriochromene Present in root
Quercetin Present in root and leaf
Rutin (quercetin-3-rutinoside) Present in aerial parts
Kaempferol Trace amounts

The flavonoid fraction is likely responsible for much of the diuretic and urinary tract protective activity attributed to gravel root. Euparin in particular has demonstrated renal and diuretic effects in pharmacological studies, supporting the traditional use for kidney stones and urinary gravel. Quercetin and rutin contribute anti-inflammatory and antioxidant effects that may protect urinary epithelium.

Volatile oil and terpenes

Eupatol Present in root volatile oil
1,8-Cineole (eucalyptol) Minor component of volatile oil
Terpinolene Present in volatile oil

The volatile oil fraction contributes to the aromatic character and may provide mild antimicrobial and anti-inflammatory activity in the urinary tract. The volatile oil content is relatively low compared to strongly aromatic herbs like juniper, but it does contribute to the overall therapeutic profile.

Other constituents

Resin Present in root
Oleic acid Present in root
Tannins Low levels in root
Calcium oxalate Present throughout plant

The resinous and fatty acid components contribute to the traditional action profile. The resin was specifically mentioned by Eclectic physicians as carrying the active diuretic principle. Tannins provide mild astringency that may help tone the urinary mucosa.

Herbal Actions

Diuretic (primary)

Increases urine production and output

The primary action and traditional rationale for use. Gravel root promotes increased urinary output through a combination of flavonoid-mediated effects (euparin, quercetin) and the overall resinous fraction. The diuretic action is considered gentle and non-irritating (unlike juniper), making it traditionally preferred for urinary conditions where the mucosa may already be inflamed. The Eclectic physicians classified it as a 'smooth muscle relaxant diuretic' that acts on the renal pelvis and ureters.

[2, 4]
Anti-inflammatory (secondary)

Reduces inflammation

Anti-inflammatory activity attributed to euparin, eupatoriochromene, quercetin, and other phenolic compounds. Particularly relevant to the urinary tract indications — reducing inflammation in the renal pelvis, ureters, and bladder. Also contributes to the traditional use for gout and rheumatic conditions.

[2]
Antispasmodic (secondary)

Relieves smooth muscle spasm

Relaxes smooth muscle of the urinary tract, particularly the ureters. This antispasmodic action on the urinary system is traditionally considered important for facilitating the passage of small kidney stones and urinary gravel. The Eclectic physicians emphasized this ureteral-relaxant property.

[4]
Astringent (mild)

Tightens and tones tissue, reduces secretions

Mild astringent action from tannin content. Helps tone and tighten urinary mucosa, reducing excessive discharge or bleeding. Contributes to efficacy in chronic urinary tract conditions with atonic, lax tissues.

[2]
Diaphoretic (mild)

Promotes perspiration

Mild diaphoretic (sweat-promoting) action noted in traditional literature, particularly when given as a warm infusion. Less prominent than the urinary actions but considered relevant to the traditional use for fever and intermittent fevers.

[4]
Nervine (mild)

Supports and calms the nervous system

Mild nervine action noted by some traditional authors. Gravel root was occasionally included in formulas for nervous irritability associated with urinary complaints — the distress and pain of renal colic, for example.

[4]

Therapeutic Indications

Urinary System

traditional

Kidney stones (nephrolithiasis) and urinary gravel

The defining traditional indication — the common name 'gravel root' directly reflects this use. Eclectic physicians relied heavily on gravel root as a litholytic (stone-dissolving) and passage-facilitating agent. The proposed mechanism combines increased urinary output (flushing), ureteral smooth muscle relaxation (facilitating passage), and potential effects on urinary pH and mineral solubility. Used for both prevention of stone recurrence and acute management. Felter and Lloyd described it as 'one of the most valuable of renal and urinary remedies.' No modern clinical trials confirm litholytic efficacy; the evidence base is entirely traditional and empirical.

[2, 4]
traditional

Urinary tract infections and chronic cystitis

Used traditionally for chronic and recurrent lower urinary tract infections, particularly those with a dull, aching quality rather than acute, sharp inflammation. The combination of diuretic flushing, anti-inflammatory activity, and mild antimicrobial effects from the volatile oil and phenolic compounds supports this indication. Often combined with other urinary herbs such as uva ursi, corn silk, or marshmallow root.

[2]
traditional

Painful or difficult urination (dysuria)

The antispasmodic and anti-inflammatory actions make gravel root applicable to various forms of painful urination. Traditionally used for strangury (painful, drop-by-drop urination), urethral irritation, and prostatic enlargement with urinary difficulty.

[4]
traditional

Benign prostatic hyperplasia (BPH) symptoms

Used by Eclectic physicians for urinary difficulty associated with prostate enlargement. The smooth muscle relaxation and anti-inflammatory effects on the lower urinary tract are the proposed mechanisms. Historical use only; no clinical trial evidence.

[4]

Musculoskeletal System

traditional

Gout and hyperuricemia

Traditional use for gout, based on the diuretic promotion of uric acid excretion combined with anti-inflammatory activity. The 'gravel' in the common name may historically have encompassed uric acid crystals as well as calcium-based urinary stones. Often combined with celery seed or nettle root for gout formulas.

[2]
traditional

Rheumatic complaints

Used in Eclectic medicine for rheumatic conditions, particularly those associated with a 'sluggish kidney' or inadequate renal elimination. The theory was that improved renal excretion of metabolic waste products would reduce joint inflammation.

[4]

Reproductive System

traditional

Dysmenorrhea and pelvic congestion

Some traditional use for menstrual pain and pelvic congestion, likely related to the antispasmodic and diuretic actions. Less commonly used for reproductive indications than for urinary ones. The Eclectic physicians noted its use for 'threatened abortion' and 'chronic uterine disease,' though these applications are largely obsolete and should not be relied upon.

[4]

Digestive System

traditional

Poor appetite and sluggish digestion

The bitter taste stimulates digestive secretions. Minor digestive use; primarily included in formulas rather than used as a standalone bitter tonic.

[4]

Energetics

Temperature

cool

Moisture

slightly dry

Taste

bitterpungentastringent

Tissue States

damp/stagnation, hot/excitation

In Western herbal energetics, gravel root is cooling and drying — consistent with its use for hot, inflamed urinary conditions with fluid stagnation (edema, urinary retention, stones). The bitter and pungent tastes stimulate elimination via the kidneys. The cooling quality makes it appropriate for urinary conditions with heat signs (burning urination, concentrated dark urine, inflammation) but less suited for cold, deficient constitutions without modification. Combines well with warming herbs (ginger, cinnamon) for cold constitutions, or with demulcents (marshmallow root, corn silk) to offset drying in sensitive urinary tracts.

Traditional Uses

Native American medicine

  • Multiple tribes used the root as a diuretic and kidney remedy — the plant is reportedly named after 'Joe Pye,' a Mohican or Abenaki healer who used it to treat typhoid fever in colonial New England
  • Cherokee used a decoction of the root for kidney and bladder problems, urinary difficulty, and urinary stones
  • Iroquois used the root decoction for kidney ailments and to help expel urinary gravel
  • Several tribes used warm infusions of the root and aerial parts as a diaphoretic for fevers
  • Used externally as a wash for skin ailments and wounds by some tribes
  • Ojibwe and other Great Lakes tribes used the plant for general urinary complaints

"Daniel Moerman's Native American Ethnobotany database records uses by at least 8 tribal groups including Cherokee, Iroquois, Ojibwe, Menominee, and Potawatomi. The most consistent use across tribes was for urinary and kidney conditions, establishing a robust ethnobotanical foundation for the 'gravel root' common name."

[5]

Eclectic medicine (American, 19th–early 20th century)

  • Considered one of the premier urinary and renal remedies in Eclectic materia medica
  • Used extensively for kidney stones (nephrolithiasis) and urinary gravel — both for acute passage and chronic prevention
  • Specific indication for 'irritation and atony of the genito-urinary apparatus' (Felter & Lloyd)
  • Used for chronic cystitis, urethritis, and prostatitis with dull, aching pelvic discomfort
  • Employed for gout and rheumatic conditions associated with 'renal insufficiency'
  • Included in compound formulas for dropsy (edema) when renal in origin
  • Specific Eclectic indication: deep, aching pain in the kidney region with scanty, dark urine

"Felter and Lloyd in King's American Dispensatory (1898) describe Eupatorium purpureum as 'one of the most valuable of renal and urinary remedies. Its action is upon the kidneys, bladder, and uterus... It relieves irritation of the bladder, urethra, and prostate gland, and the pain and distress of urinary calculi.' The Eclectics considered it specific for 'vesical irritation with frequent desire to urinate, deep-seated, dull, aching pelvic and renal pain.'"

[4]

Western herbal medicine (modern)

  • Continues to be used as a urinary tract remedy for kidney stones, gravel, and chronic UTI
  • Included in formulas for BPH and prostate-related urinary difficulty
  • Used for gout and rheumatic conditions as a supportive renal eliminative
  • Often combined with other urinary herbs: marshmallow root (demulcent), corn silk (soothing diuretic), uva ursi (antimicrobial), hydrangea root (litholytic)
  • Modern herbalists typically limit duration of use and prefer PA-tested material due to pyrrolizidine alkaloid concerns

"David Hoffmann in Medical Herbalism (2003) includes gravel root as a key urinary remedy, noting its value for kidney stones, cystitis, and urethritis. Modern practice is more cautious about PA content than Eclectic-era use."

[2]

Modern Research

narrative review

Pyrrolizidine alkaloid content and hepatotoxicity risk

Analytical studies have confirmed the presence of 1,2-unsaturated pyrrolizidine alkaloids (primarily echinatine and its N-oxide) in Eutrochium purpureum root. The PA content is generally considered low compared to high-PA species (Symphytum, Senecio) but is measurable and toxicologically significant with sustained use.

Findings: PA content varies by plant part, chemotype, and growing conditions. Root and rhizome may contain higher PA concentrations than aerial parts. The 1,2-unsaturated structure of echinatine means it is metabolically activated to hepatotoxic pyrrole intermediates by CYP3A4 enzymes. Chronic exposure can cause hepatic veno-occlusive disease (sinusoidal obstruction syndrome). The German BfR and EMA recommend limiting PA intake to ≤0.35 µg/day for internal use products intended for more than 2 weeks.

Limitations: Limited quantitative analytical data specific to E. purpureum — most PA research focuses on comfrey (Symphytum) and Senecio species. PA content ranges in gravel root have not been comprehensively mapped across cultivars and geographic populations.

[1, 3]

in vivo

Diuretic activity — preclinical evidence

Pharmacological investigations of Eutrochium/Eupatorium species have demonstrated diuretic activity in animal models, consistent with the extensive traditional use as a kidney and urinary remedy.

Findings: Aqueous extracts of Eupatorium purpureum root produced significant diuresis in rat models, increasing urinary volume and sodium excretion. The diuretic mechanism appears to involve increased renal blood flow and glomerular filtration rather than direct tubular effects (unlike loop diuretics or thiazides). The flavonoid fraction (including euparin) appears to be the primary contributor to diuretic activity.

Limitations: Animal studies only; no human clinical trials. Older literature — some studies from mid-20th century with limited methodological rigor by modern standards. Dose extrapolation to humans is uncertain.

[2]

in vitro

Euparin — anti-inflammatory and diuretic properties

Euparin, the characteristic benzofuran derivative found in Eutrochium and related species, has been studied in vitro and in vivo for anti-inflammatory and renal-protective properties.

Findings: Euparin demonstrates inhibition of pro-inflammatory mediators including COX-2 and various cytokines in cell-based assays. The benzofuran skeleton is a pharmacologically active scaffold shared by several bioactive natural products. Euparin and related compounds also show mild antimicrobial activity against common urinary tract pathogens in vitro.

Limitations: Primarily in vitro data. Bioavailability and tissue distribution of euparin after oral administration of gravel root preparations are not well characterized.

[2]

narrative review

Quercetin and rutin — urinary tract anti-inflammatory effects

The flavonoids quercetin and rutin, present in gravel root, have been extensively studied independently for their anti-inflammatory, antioxidant, and urinary protective properties.

Findings: Quercetin reduces oxidative stress and inflammation in renal tissue. Animal studies demonstrate protective effects against calcium oxalate crystal formation and adhesion to renal tubular epithelium. Quercetin supplementation has been associated with reduced urinary calcium oxalate stone formation in rat models. These findings provide a pharmacological rationale for the litholytic (anti-stone) tradition of gravel root, though the quercetin content in typical doses of gravel root preparations has not been quantified relative to effective doses in these studies.

Limitations: Evidence is for isolated quercetin, not gravel root as a whole-plant preparation. The quercetin content in therapeutic doses of gravel root is likely much lower than doses used in quercetin-specific studies.

[2]

narrative review

Antispasmodic effects on ureteral smooth muscle

Traditional claims of ureteral relaxation and facilitated stone passage have some pharmacological plausibility based on the flavonoid and volatile oil content, though direct studies on gravel root extracts are lacking.

Findings: Flavonoids as a class demonstrate smooth muscle relaxant activity, particularly on visceral smooth muscle including the ureter and bladder. Quercetin specifically has shown relaxant effects on isolated smooth muscle preparations. The volatile oil components (monoterpenes) may also contribute to antispasmodic effects. These general pharmacological properties of gravel root's constituents support the traditional indication for renal colic and facilitated stone passage, though direct evidence using gravel root extracts on ureteral tissue is not available.

Limitations: Entirely mechanistic inference from constituent pharmacology. No direct studies using gravel root whole extracts on ureteral smooth muscle.

[2]

narrative review

Safety assessment — EMA and regulatory perspective on PA-containing herbs

The European Medicines Agency and other regulatory bodies have established frameworks for assessing the safety of herbal medicines containing pyrrolizidine alkaloids, with direct implications for gravel root use.

Findings: The EMA Committee on Herbal Medicinal Products (HMPC) established a maximum daily intake of 0.35 µg PA for herbal products intended for use longer than 2 weeks, and 1.0 µg/day for products used 2 weeks or less. These limits apply to the sum of 1,2-unsaturated PAs and their N-oxides. For gravel root, this means that (1) PA-tested material should be preferred, (2) duration of internal use should be limited, and (3) practitioners should weigh PA risk against therapeutic benefit for each patient.

Limitations: The 0.35 µg limit is based on a margin-of-exposure approach using cancer bioassay data and is intentionally conservative. Some toxicologists argue that the actual risk from low-PA herbs like gravel root used intermittently is very low.

[3]

Preparations & Dosage

Decoction

Strength: 2–4 g dried root per 300 mL water

Add 2–4 g of dried, cut-and-sifted gravel root to 300 mL of cold water. Bring to a boil, then reduce heat and simmer gently for 15–20 minutes. Strain while hot. The decoction has a mildly bitter, slightly aromatic taste.

Adult:

2–4 g dried root per cup. One cup (200–250 mL) 3 times daily.

Frequency:

3 times daily between meals.

Duration:

Limit to 2–4 weeks of continuous use. Do not exceed 6 weeks without practitioner supervision and liver function monitoring.

Pediatric:

Not recommended for children due to PA content.

Decoction is the traditional preparation method for the hard, woody root. Hot water extraction may extract fewer pyrrolizidine alkaloids than hydroalcoholic extraction, though this is not guaranteed. The Eclectic physicians generally preferred decoction for urinary indications.

[2, 4]

Tincture

Strength: 1:5, 40–50% ethanol

Macerate dried gravel root in ethanol-water menstruum. Standard ratio 1:5 in 40–50% ethanol. Macerate for 4–6 weeks, shaking regularly. Press and filter.

Adult:

2–4 mL, 3 times daily.

Frequency:

3 times daily.

Duration:

Limit to 2–4 weeks without practitioner supervision.

Pediatric:

Not recommended for children.

Tincture may extract a broader range of PAs than water decoction due to the ethanol solvent. Practitioners preferring lower PA exposure may favor decoction. However, tincture allows precise dosing and is more convenient for formula work. PA-free or PA-reduced tinctures may be available from manufacturers who process specifically to reduce PA content.

[2]

Capsule / Powder

Strength: Crude dried root powder, 500–1000 mg per capsule.

Dried, powdered gravel root in capsules. Ensure product is from a reputable source with PA testing.

Adult:

500–1000 mg per capsule, 2–3 capsules daily (1–3 g total).

Frequency:

2–3 times daily with meals.

Duration:

Limit to 2–4 weeks.

Pediatric:

Not recommended.

Capsule form bypasses the taste but provides crude root powder with the full range of constituents including PAs. PA-tested material is essential for capsule products.

[2]

Infusion (Tea)

Strength: 1–2 g per 250 mL

Pour 250 mL boiling water over 1–2 g of dried, cut gravel root (or use the less-hard aerial flowering parts). Cover and steep 15–20 minutes. Strain.

Adult:

1–2 g per cup. One cup 2–3 times daily.

Frequency:

2–3 times daily.

Duration:

Short-term use preferred.

Pediatric:

Not recommended.

Infusion is less efficient than decoction for extracting the hard root material. Better suited for the aerial parts or finely powdered root. A lighter preparation that may be appropriate for milder urinary maintenance.

[2]

Glycerite

Strength: 1:5, 60% glycerin

Macerate dried gravel root in vegetable glycerin-water mixture (60% glycerin, 40% water). Steep 6–8 weeks, shaking regularly.

Adult:

3–5 mL, 3 times daily.

Frequency:

3 times daily.

Duration:

Short-term use (2–4 weeks).

Pediatric:

Not recommended due to PA concerns.

Glycerite provides an alcohol-free alternative. Glycerin is a less efficient extracting solvent than ethanol, which may result in lower overall constituent extraction (including potentially lower PA extraction). Suitable for patients avoiding alcohol.

[2]

Safety & Interactions

Class 2d

Other specific use restrictions apply (AHPA Botanical Safety Handbook)

Contraindications

absolute Pregnancy

Gravel root contains pyrrolizidine alkaloids which are teratogenic and potentially embryotoxic. PAs cross the placental barrier. All PA-containing herbs are absolutely contraindicated in pregnancy regardless of PA concentration. Additionally, some traditional sources note emmenagogue properties.

absolute Lactation

Pyrrolizidine alkaloids and their metabolites are excreted in breast milk. Infant livers are particularly vulnerable to PA-induced hepatotoxicity due to immature metabolic pathways. All PA-containing herbs are contraindicated during breastfeeding.

absolute Pre-existing liver disease (hepatitis, cirrhosis, fatty liver disease)

PA-induced hepatotoxicity risk is significantly increased in patients with compromised liver function. The liver's capacity to detoxify reactive PA metabolites is reduced in hepatic disease.

absolute Children under 12 years

Immature hepatic metabolism increases vulnerability to PA-induced liver damage. Not recommended for pediatric use.

relative Concurrent use with other PA-containing herbs (comfrey, coltsfoot, borage, boneset)

Additive PA exposure from multiple sources increases cumulative hepatotoxicity risk. Total PA intake from all sources must be considered.

Drug Interactions

Drug / Class Severity Mechanism
Hepatotoxic medications (acetaminophen/paracetamol at high doses, methotrexate, isoniazid, valproic acid, statins) (Hepatotoxic drugs) moderate Additive hepatotoxic risk. PA metabolites and hepatotoxic drugs both stress hepatic detoxification pathways. Concurrent use increases cumulative liver injury risk.
CYP3A4 substrates (many medications including cyclosporine, certain statins, calcium channel blockers, protease inhibitors) (CYP3A4 substrates) theoretical PAs are metabolized by CYP3A4. Competition for CYP3A4 metabolism between PAs and co-administered drugs could theoretically alter drug levels, though this has not been demonstrated with gravel root specifically.
Lithium (Mood stabilizers) moderate The diuretic action of gravel root may reduce renal lithium clearance, potentially increasing serum lithium levels to toxic concentrations. This is a class effect of diuretic herbs.
Prescription diuretics (furosemide, hydrochlorothiazide, spironolactone) (Diuretics) moderate Additive diuretic effect may cause excessive fluid loss, electrolyte imbalance (hyponatremia, hypokalemia), and hypotension.
Anticoagulants and antiplatelet agents (warfarin, heparin, aspirin, clopidogrel) (Antithrombotic agents) theoretical Quercetin and other flavonoids in gravel root have demonstrated antiplatelet and mild anticoagulant activity in vitro. Theoretical risk of additive effects with anticoagulant medications.

Pregnancy & Lactation

Pregnancy

unsafe

Lactation

unsafe

ABSOLUTELY CONTRAINDICATED in pregnancy and lactation due to pyrrolizidine alkaloid content. PAs cross the placental barrier and are excreted in breast milk. PA-induced hepatic veno-occlusive disease has been documented in infants exposed to PA-containing herbs via breast milk. The EMA and all major pharmacopeial authorities classify PA-containing herbs as contraindicated in pregnancy and lactation. No amount of gravel root is considered safe during pregnancy or breastfeeding.

Adverse Effects

uncommon Gastrointestinal discomfort (nausea, stomach upset) — Mild GI effects from the bitter constituents. More likely on an empty stomach or at higher doses.
very-rare Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) — Theoretical risk with chronic, sustained use due to PA content. Symptoms include right upper quadrant pain, hepatomegaly, ascites, and jaundice. Primarily documented with higher-PA herbs (comfrey, Senecio) but the mechanism applies to all 1,2-unsaturated PA-containing plants. No published case reports specifically attributed to E. purpureum at therapeutic doses.
rare Allergic reaction (contact dermatitis, rare systemic allergy) — Possible in individuals with Asteraceae/Compositae family allergy. Cross-reactivity with ragweed, chamomile, echinacea, and other Asteraceae members.

References

Monograph Sources

  1. [1] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition: Eupatorium purpureum. CRC Press, Boca Raton (2013)
  2. [2] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) : 556-557

Clinical Studies

  1. [3] European Medicines Agency, Committee on Herbal Medicinal Products. Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs). EMA/HMPC/893108/2011 Rev. 1 (2021)

Traditional Texts

  1. [4] Felter HW, Lloyd JU. King's American Dispensatory: Eupatorium Purpureum. Ohio Valley Company, Cincinnati (1898)
  2. [5] Moerman DE. Native American Ethnobotany. Timber Press, Portland, OR (1998)

Last updated: 2026-03-23 | Status: review

Unlock the Full Materia Medica

This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.

No spam, ever. Unsubscribe anytime.

Full botanical illustration of Eutrochium purpureum (L.) E.E.Lamont

Public domain botanical illustration